News

JPMorgan Adjusts Price Target for Chart Industries Amid Growth Concerns

JPMorgan Adjusts Price Target for Chart Industries Amid Growth Concerns

JPMorgan Adjusts Price Target for Chart Industries

In a recent analysis, JPMorgan has made the decision to revise its price target for Chart Industries (NYSE: GTLS), well-known for its manufacturing of specialized equipment catering to diverse needs in the energy and industrial gas sectors. The price target has shifted from $150.00 to $145.00, with the firm holding onto a Neutral rating for the stock amidst evolving market dynamics.

Growth Projections Under Review

This adjustment signifies JPMorgan's cautious outlook for the remainder of 2024. Factors influencing this perspective include an unpredictable political climate in the U.S. and the anticipated delays in high-value orders. Specifically, the banking giant forecasts that Chart Industries' revenue for the third quarter will be around $1.09 billion. This figure represents a notable decline of 4.2% from prior estimates and falls 3.9% short of the consensus revenue projection of $1.13 billion.

Operational Efficiency Amidst Revenue Adjustments

Despite the downward revisions in revenue expectations, Chart Industries is expected to uphold its strong margins. JPMorgan projects that the company's EBITDA for the third quarter will come in at $266 million, slightly below the consensus estimate of $280 million. This outlook reflects not only a lower revenue forecast but also an anticipated growth in overall revenue of 5% quarter over quarter, which is below the consensus figure of 9%.

Strategic Shift Under Leadership

CEO Jill Evanko has driven significant strategic changes within the company, focusing more on services and project-based work rather than traditional equipment sales. This evolution allows for revenue recognition through the percentage of completion accounting method, which, while potentially leading to greater fluctuations in earnings, is generally associated with higher margins.

Revising Order Estimates

In addition to the price target revision, JPMorgan adjusted its inbound order projections for Chart Industries. The firm reduced its expectations for third-quarter 2024 orders to $1.1 billion, down from $1.2 billion, and for the fourth quarter from $1.3 billion to $1.2 billion. These revisions stem from the anticipation that larger orders might be postponed, pushing relevant revenue into 2025.

Recent Highlights and Market Reception

Interestingly, Chart Industries has reported a promising 12% uptick in orders, reaching a total of $1.16 billion, alongside an 18.8% increase in quarterly sales, totaling $1.04 billion in Q2 2024. Despite these positive figures, the company anticipates its overall sales for 2024 may come in lower than originally guided and below analysts' estimates.

Market Reactions and Ratings Changes

The corporate landscape surrounding Chart Industries remains dynamic. Following a merger with Howden earlier this year, Morgan Stanley upgraded the company from Equalweight to Overweight, assigning a fresh price target of $175. On the other hand, Stifel reiterated a Buy rating despite the recent drop in guidance primarily due to delays in revenue recognition.

Citi's Conservative Adjustment

Citi has also re-evaluated their stance on the company, decreasing its price target from $210 to $190 while maintaining a Buy rating. This decision comes in light of the challenges related to backlog conversion and the revelation that Chart Industries' second-quarter earnings did not meet expectations, prompting a reduction in the EBITDA guidance for the year.

InvestingPro Insights

To further illuminate the financial landscape of Chart Industries, recent insights from InvestingPro have emerged, noting a striking 70.25% growth in revenue over the past year, culminating at $3.9 billion as of Q2 2024. This growth aligns with JPMorgan’s observations and highlights the company's pivot towards more lucrative service and project-centric operations.

Future Projections and Market Position

Investors can anticipate persistent growth, with analysts forecasting continued sales advancements this year despite the moderate revenue growth expectations outlined by JPMorgan. Additionally, Chart Industries' net income is projected to rise, providing a buffer against the backdrop of revised EBITDA guidance.

Valuation and Growth Potential

It is also noteworthy that Chart Industries is trading at a relatively low P/E ratio compared to its projected earnings growth, presenting a PEG ratio of merely 0.11 as of Q2 2024. This could suggest that the stock remains undervalued, especially when considering the company’s promising growth trajectory despite the recent price adjustments.

Frequently Asked Questions

What led to JPMorgan's price target reduction for Chart Industries?

JPMorgan lowered the price target due to cautious growth forecasts influenced by a volatile political climate and anticipated delays in significant orders.

How does Chart Industries' strategic focus differ now?

The company, under CEO Jill Evanko, is emphasizing service and project work over equipment sales, which could lead to higher margins through different revenue recognition methods.

What are the recent financial highlights for Chart Industries?

Chart Industries reported a 12% increase in orders and an 18.8% rise in sales in Q2 2024, although its full-year sales may underperform earlier guidance.

Which firms have changed their ratings on Chart Industries recently?

Following recent developments, Morgan Stanley upgraded the stock to Overweight, while Citi lowered its target price but maintained a Buy rating amidst concerns about backlog conversions.

What does the low PEG ratio indicate about Chart Industries?

A low PEG ratio suggests that the stock may be undervalued in relation to its growth potential, which might be attractive for investors seeking long-term gains.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Western Microsurgical Expands Through Strategic Acquisitions

Updated Category News Views 0

Western Microsurgical's Bold Moves Western Microsurgical (WMS) is out here making waves, pulling off some serious strategic plays with the acquisitions of Q Surgical and Proficient Surgical. Now, this ain't some fly-by-night decision—this is about securing territory and leveling up their game in surgical microscopes and operating room supplies. With a footprint that'll...

Continue Reading
North Fork Mono Casino Opens: A $750 Million Bet

Updated Category News Views 0

A New Spin in Madera Cue the fanfare, folks! The North Fork Mono Casino just threw open its doors earlier than expected today, marking a hefty $750 million wager right in the heart of California's Central Valley. It's a big deal managed by Station Casinos, part of Red Rock Resorts, Inc. (NASDAQ: RRR)—teaming up with the North Fork Rancheria of Mono Indians for a...

Continue Reading
Latham & Harvey Boost Fund Formation With AI Tech

Updated Category News Views 52

AI Joins Forces with Legal Expertise Latham & Watkins LLP and Harvey are teaming up to revolutionize how fund formation gets done. They're jumping into the AI waters with both feet, aiming to make the fund documentation process less of a nightmare and more of a breeze for lawyers. The idea isn't just to cut down on the grunt work, but to let attorneys zero in on what's...

Continue Reading
Bank of America Faces Securities Fraud Suit Amidst Stock Dip

Updated Category News Views 104

Bank of America in Hot Water Over Compliance Issues No one likes waking up to a legal mess, especially shareholders. Bank of America finds itself knee-deep in a class action lawsuit. What kicked off this chain reaction of legal turmoil? Allegations that the bank downplayed their dirty laundry concerning the Bank Secrecy Act and anti-money laundering compliance failures....

Continue Reading
Vanda's NEREUS Outperforms in GLP-1 Vomiting Study

Updated Category News Views 45

A Surprising Breakthrough in Vomiting Prevention You don't need to be an old hand on Wall Street to see that when a biotech company rolls out positive trial results, ears perk up. Today, Vanda Pharmaceuticals' announcement that their NEREUS™ (tradipitant) drug aced Study 3601 is catching more eyes than initially expected. It's not just about hitting numbers; it's about...

Continue Reading
Philips’ Beauty Tech Trends Promise Intimacy by 2027

Updated Category News Views 146

Beauty Tech Takes a Personal Turn It's 2026, and in the beauty industry, folks are trading flashy for the intimate and intelligent. Philips, that stalwart of tech innovation, is waving the banner, revealing three beauty trends we can't ignore if we plan to keep up with the times. The Rise of Intelligent Guidance First off, everyone and their dog seems to ask how tech is...

Continue Reading
Globe Life Faces Investor Scrutiny Over Leadership

Updated Category News Views 21

Shareholders Put Globe Life Under the Microscope There's something cooking at Globe Life Inc., and it isn't a savory stew of shareholder satisfaction. See, when an investor rights firm like Halper Sadeh LLC starts poking around, suspecting a breach of fiduciary duty by the folks at the top, you know there's some smoke. Questions are looming over whether some brass at...

Continue Reading
Infotech's 2027 Trends: AI Reshapes Strategy & Risk

Updated Category News Views 53

AI's Growing Footprint in Global Strategies Let's get straight to it: AI's not just playing in the background anymore—it's front and center, dipping its fingers into everything from budget spreadsheets to boardroom agendas. Infotech's annual Tech Trends 2027 report isn't mincing words about AI either, spotlighting 14 trends across four themes that tech leaders better be...

Continue Reading
Johnson Controls FY26 Results Highlight Growth Momentum

Updated Category News Views 176

Unpacking Johnson Controls' Fiscal 2026 Performance You know, it's not often that a company hits a home run with back-to-back quarters, but Johnson Controls (NYSE:JCI) seems to be swinging for the fences as they wrap up fiscal 2026. What we've got here is a robust set of financial results, showcasing not just growth but momentum that's got investors humming. We're talking...

Continue Reading
Omnichat's $10M Series A: Scaling AI for Global Reach

Updated Category News Views 135

Omnichat Secures Funding to Transform Commerce Well, folks, they're calling it a smart move—or a gamble, depending on who you ask. Omnichat just snagged a tidy $10 million from a Series A, led by Openspace Capital. They're pouring this cash into scaling what they call the 'Agentic AI' platform, a bevy of AI agents poised to shake up the marketing, sales, and customer...

Continue Reading

Top 5 Most Recently Viewed Articles

Transform Your Investment: What $1,000 Could Mean Today

Updated Category News Views 30

Transform Your Investment Journey with Booking Holdings Investing in the stock market can feel like a daunting task, yet some companies have proven to be extraordinarily rewarding over the years. One such company is Booking Holdings (NASDAQ: BKNG), which has delivered spectacular returns to its investors. Over the past two decades, its annualized return has outstripped...

Continue Reading
Mirantis Excels in Container Management: 2024 Gartner Recognition

Updated Category News Views 181

Mirantis Recognized as a Challenger by Gartner Mirantis recently announced with pride that it has been named a Challenger in the 2024 Gartner Magic Quadrant for Container Management. This esteemed recognition highlights Mirantis alongside prominent companies such as AWS, Google, and Microsoft. It reflects Mirantis' commitment to giving organizations exceptional control...

Continue Reading
SolarBank Secures $1.5 Million for Innovative EV Charger Projects

Updated Category News Views 172

The Big Picture: EV Charging Initiatives SolarBank has thrown its hat into the ring by applying for $1.5 million in grants for three fast EV charger projects. Now, these aren’t just any chargers; they’re positioned to be pivotal in SolarBank's evolving narrative as a frontrunner in the clean energy sector. The significance here? They’re not merely seeking...

Continue Reading
Nature's Way Unveils Exciting Sambucus Ultra Immune Chews

Updated Category News Views 151

Nature's Way Introduces Innovative Immune Support Chews Building on its award-winning Sambucus brand, Nature's Way presents a delightful new format that transforms immune support into a fun experience. The recently launched Sambucus Ultra Immune Juicy Burst is designed not just to support immune health but to do so in a tasty, enjoyable way that everyone can appreciate. A...

Continue Reading
Getinge's Hemopro 3 Boosts Endoscopic Vessel Harvesting

Updated Category News Views 8

Getinge's Latest Evolution in Endoscopic Vessel Harvesting Witnessing Getinge's launch of the Vasoview Hemopro 3 feels like catching the climax of a meticulous medical drama. This Swedish giant is pushing the envelope in coronary artery bypass grafting (CABG) procedures with this state-of-the-art Endoscopic Vessel Harvesting (EVH) System. For insiders in the healthcare...

Continue Reading